Move On Up (MOU)
Brief description of study
The MoVEonUp Study is a NIH-funded study for women who are 70 years or older and experience urinary incontinence (bladder leaks). The study will test an exercise and bladder training program to reduce the risk of falling and improve bladder symptoms. No travel for the study is required. Study visits will be performed at home with research staff. The length of the study participation is 12-months.
Detailed description of study
Participants will be randomized to one of two groups, a home-based exercise group or a control group.
The home-based exercise intervention group will participate in the exercise intervention consisting of strength and balance training, bladder retraining, urge suppression techniques, and home hazard reduction.
The control group will receive an educational booklet on falls prevention and behavioral treatment of UI. This group will have access to the exercise intervention at the conclusion of the study.
The study will last for a period of 12 months. During the study participants will be asked to complete 3-5 in-home visits and monthly check in phone calls.
Compensation up to $275 will be provided if all study visits are completed.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: urinary incontinence, UI, urge incontinence, urine leakage
-
Age: 70 years - 100 years
-
Gender: Female
Inclusion
- Female and age 70 or older.
- Living independently in the community.
- Able to read and understand English.
- Low physical activity.
- Ambulatory (not confined to bed or wheelchair OR ability to walk with or without an assistive device.)
- Self-reported moderate to severe urge-urinary incontinence.
Exclusion
- Pelvic organ prolapse.
- Undergoing active treatment for cancer.
- Uncorrected visual or hearing loss.
- Progressive neurodegenerative disease e.g. Parkinson's disease, multiple sclerosis.
- History of stroke or carotid sensitivity (i.e. syncopal falls).
- Unstable cardiac disease.
- Fracture or joint replacement within the last six months.
- Significant cognitive impairment.
- Unwillingness to be randomized.
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
